Charles Moore has a long-proven track record in both print and digital journalism, touching on a wide range of subjects, from biotech and healthcare to politics and technology. He contributes substantial feature articles research and development for the news site, particularly pertaining to technology.
Linda Reinstein, president and CEO of the Asbestos Disease Awareness Organization (ADAO), has released a sharply worded statement protesting the U.S. House of Representatives’ passage of the Furthering Asbestos Claim ... Read more
A Feb. 23 signing ceremony at Great Britain’s House of Lords made the Victor Dahdaleh Foundation‘s recent £5 million ($6.2 million) donation to the British Lung Foundation (BLF) official. The ... Read more
The National Comprehensive Cancer Network (NCCN), an alliance of 27 major U.S. cancer centers, has expanded its recommendation for first-line pleural mesothelioma treatment to include the monoclonal antibody drug Avastin (bevacizumab) as a combination therapy ... Read more
Exton, Pennsylvania based Morphotek, Inc., the U.S. biopharmaceutical subsidiary of Tokyo-based global health care pharmaceutical company Eisai Co.,Ltd. — specializing in development of protein and antibody products through use of novel ... Read more
Zug, Switzerland, based SELLAS Life Sciences Group, (SELLAS), a 2012 startup clinical-stage biopharmaceutical company focused on development of novel cancer therapies, reports that positive data from the company’s clinical studies ... Read more